Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

Fig. 2

Disease-free survival (DFS) and cancer specific survival (CSS) curves of CRC generated by the Kaplan–Meier method and compared by log-rank test. a Patients with high TMEM180 expression exhibited poorer DFS than those with low TMEM180 expression, but the difference was not significant (p = 0.324). b Patients with high TMEM180 expression exhibited significantly poorer CSS than those with low TMEM180 expression (p = 0.028)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us